CO7240358A2 - Uso de 2-metileno-19-nor-(20s)-1a, 25- dihidroxivitamina d3 para tratar el hiperparatiroidismo secundario - Google Patents
Uso de 2-metileno-19-nor-(20s)-1a, 25- dihidroxivitamina d3 para tratar el hiperparatiroidismo secundarioInfo
- Publication number
- CO7240358A2 CO7240358A2 CO15013584A CO15013584A CO7240358A2 CO 7240358 A2 CO7240358 A2 CO 7240358A2 CO 15013584 A CO15013584 A CO 15013584A CO 15013584 A CO15013584 A CO 15013584A CO 7240358 A2 CO7240358 A2 CO 7240358A2
- Authority
- CO
- Colombia
- Prior art keywords
- dihydroxyvitamin
- methylene
- secondary hyperparathyroidism
- treat secondary
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se divulga el uso de 2-metileno-19-nor-(20S)-1α,25-dihidroxivitamina D3 para tratar y/oprevenir el hiperparatiroidismo secundario y/o sus síntomas acompañantes en un sujeto quetiene o está en riesgo de desarrollar hiperparatiroidismo secundario sin inducirhipercalcemia en el sujeto.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261666264P | 2012-06-29 | 2012-06-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO7240358A2 true CO7240358A2 (es) | 2015-04-17 |
Family
ID=47997980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO15013584A CO7240358A2 (es) | 2012-06-29 | 2015-01-23 | Uso de 2-metileno-19-nor-(20s)-1a, 25- dihidroxivitamina d3 para tratar el hiperparatiroidismo secundario |
Country Status (19)
Country | Link |
---|---|
US (4) | US9205096B2 (es) |
EP (1) | EP2866811A1 (es) |
JP (1) | JP2015522015A (es) |
KR (1) | KR20150030673A (es) |
CN (1) | CN104394871A (es) |
AU (1) | AU2013281217B2 (es) |
BR (1) | BR112014032847A2 (es) |
CA (1) | CA2877680C (es) |
CL (1) | CL2014003565A1 (es) |
CO (1) | CO7240358A2 (es) |
HK (1) | HK1206600A1 (es) |
IL (1) | IL236184A0 (es) |
MX (1) | MX2015000076A (es) |
MY (1) | MY172886A (es) |
NZ (1) | NZ703347A (es) |
RU (1) | RU2666995C2 (es) |
SG (1) | SG11201408731WA (es) |
WO (1) | WO2014003849A1 (es) |
ZA (1) | ZA201500119B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2866811A1 (en) * | 2012-06-29 | 2015-05-06 | Wisconsin Alumni Research Foundation | USE OF 2-METHYLENE-19-NOR-(20S)-1 alpha,25-DIHYDROXYVITAMIN D³ TO TREAT SECONDARY HYPERPARATHYROIDISM |
RU2019140645A (ru) | 2013-09-27 | 2020-01-27 | Кодексис, Инк. | Автоматизированный скрининг вариантов фермента |
AU2014324670B2 (en) * | 2013-09-27 | 2019-11-21 | Codexis, Inc. | Structure based predictive modeling |
CN103533522A (zh) * | 2013-10-25 | 2014-01-22 | 从兴技术有限公司 | 短信稽核的方法及系统 |
CR20170085A (es) * | 2014-08-07 | 2017-04-25 | Opko Ireland Global Holdings Ltd | Terapia adjuntiva con 25-hidroxi vitamina d |
US9539264B2 (en) | 2014-12-30 | 2017-01-10 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics |
US10369161B2 (en) | 2014-12-30 | 2019-08-06 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism |
US10105375B2 (en) | 2016-08-30 | 2018-10-23 | Wisconsin Alumni Research Foundation | Combination of low dose 2-methylene-19-nor-(20S)1α, 25-dihydroxyvitamin D3 and calcimimetics to treat secondary hyperparathyroidism |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040043971A1 (en) | 1995-04-03 | 2004-03-04 | Bone Care International, Inc. | Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
US6306844B1 (en) | 1997-03-17 | 2001-10-23 | Wisconsin Alumni Research Foundation | Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength |
US5843928A (en) | 1997-03-17 | 1998-12-01 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin D compounds |
US6136799A (en) | 1998-04-08 | 2000-10-24 | Abbott Laboratories | Cosolvent formulations |
US6673782B2 (en) | 1999-04-29 | 2004-01-06 | Wisconsin Alumni Research Foundation | Treatment of systemic lupus erythematosis |
ATE319455T1 (de) | 2000-03-27 | 2006-03-15 | Wisconsin Alumni Res Found | Vitamin d-verbindungen zur behandlung von chronischer tranplantatnephropathie bei nieren transplantieren patienten |
KR100572957B1 (ko) | 2000-07-14 | 2006-04-24 | 위스콘신 얼럼나이 리서어치 화운데이션 | 골 강도를 증가시키기 위한2-메틸렌-19-노르-20(S)-1α,25-디히드록시비타민 D3의용도 |
US20080249068A1 (en) | 2002-09-05 | 2008-10-09 | Deluca Hector F | Method of Extending the Dose Range of Vitamin D Compounds |
US20050124591A1 (en) | 2003-07-29 | 2005-06-09 | Jin Tian | Use of vitamin Ds to treat kidney disease |
US20060171983A1 (en) | 2003-07-30 | 2006-08-03 | Jin Tian | Use of Vitamin D receptor activators or Vitamin D analogs to treat cardiovascular disease |
KR20060040744A (ko) * | 2003-09-19 | 2006-05-10 | 화이자 프로덕츠 인크. | 쇠약, 근육 손상 또는 근육감소증 치료용2-알킬리덴-19-노르-비타민 d 유도체 |
US7704980B2 (en) | 2003-10-08 | 2010-04-27 | Wisconsin Alumni Research Foundation | Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds |
US7214671B2 (en) | 2004-02-19 | 2007-05-08 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases |
EP1853274B1 (en) | 2005-02-11 | 2013-01-23 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor- (20s-24s) - 1alpha, 25-dihydroxyvitamine-d2 |
US7528122B2 (en) * | 2006-02-02 | 2009-05-05 | Wisconsin Alumni Research Foundation | Vitamin D analog—NEL, methods and uses thereof |
US20110034426A1 (en) * | 2009-08-03 | 2011-02-10 | Wisconsin Alumni Research Foundation | Method of Preventing Renal Disease and Treating Symptoms Thereof |
WO2011119610A2 (en) | 2010-03-23 | 2011-09-29 | Wisconsin Alumni Research Foundation | (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3 |
EP2866811A1 (en) * | 2012-06-29 | 2015-05-06 | Wisconsin Alumni Research Foundation | USE OF 2-METHYLENE-19-NOR-(20S)-1 alpha,25-DIHYDROXYVITAMIN D³ TO TREAT SECONDARY HYPERPARATHYROIDISM |
-
2013
- 2013-03-14 EP EP13712121.6A patent/EP2866811A1/en not_active Withdrawn
- 2013-03-14 JP JP2015520165A patent/JP2015522015A/ja active Pending
- 2013-03-14 CA CA2877680A patent/CA2877680C/en not_active Expired - Fee Related
- 2013-03-14 RU RU2015102831A patent/RU2666995C2/ru not_active IP Right Cessation
- 2013-03-14 KR KR20147036464A patent/KR20150030673A/ko not_active Application Discontinuation
- 2013-03-14 MY MYPI2014003594A patent/MY172886A/en unknown
- 2013-03-14 MX MX2015000076A patent/MX2015000076A/es unknown
- 2013-03-14 CN CN201380034681.7A patent/CN104394871A/zh active Pending
- 2013-03-14 NZ NZ703347A patent/NZ703347A/en not_active IP Right Cessation
- 2013-03-14 WO PCT/US2013/031574 patent/WO2014003849A1/en active Application Filing
- 2013-03-14 US US13/828,090 patent/US9205096B2/en not_active Expired - Fee Related
- 2013-03-14 BR BR112014032847A patent/BR112014032847A2/pt not_active Application Discontinuation
- 2013-03-14 AU AU2013281217A patent/AU2013281217B2/en not_active Ceased
- 2013-03-14 SG SG11201408731WA patent/SG11201408731WA/en unknown
-
2014
- 2014-03-07 US US14/201,091 patent/US9034853B2/en not_active Expired - Fee Related
- 2014-12-11 IL IL236184A patent/IL236184A0/en unknown
- 2014-12-29 CL CL2014003565A patent/CL2014003565A1/es unknown
-
2015
- 2015-01-08 ZA ZA2015/00119A patent/ZA201500119B/en unknown
- 2015-01-23 CO CO15013584A patent/CO7240358A2/es unknown
- 2015-07-24 HK HK15107093.4A patent/HK1206600A1/xx unknown
- 2015-11-20 US US14/947,142 patent/US9717744B2/en not_active Expired - Fee Related
-
2017
- 2017-05-24 US US15/604,069 patent/US10046000B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2877680C (en) | 2017-08-29 |
US20140005152A1 (en) | 2014-01-02 |
EP2866811A1 (en) | 2015-05-06 |
SG11201408731WA (en) | 2015-01-29 |
HK1206600A1 (en) | 2016-01-15 |
US20160136184A1 (en) | 2016-05-19 |
CN104394871A (zh) | 2015-03-04 |
US9205096B2 (en) | 2015-12-08 |
US9034853B2 (en) | 2015-05-19 |
CL2014003565A1 (es) | 2015-08-28 |
US20140187522A1 (en) | 2014-07-03 |
MX2015000076A (es) | 2015-04-10 |
RU2015102831A (ru) | 2016-08-20 |
AU2013281217B2 (en) | 2017-03-02 |
US10046000B2 (en) | 2018-08-14 |
BR112014032847A2 (pt) | 2017-06-27 |
AU2013281217A1 (en) | 2015-01-22 |
RU2666995C2 (ru) | 2018-09-13 |
US20170252360A1 (en) | 2017-09-07 |
ZA201500119B (en) | 2017-11-29 |
US9717744B2 (en) | 2017-08-01 |
JP2015522015A (ja) | 2015-08-03 |
CA2877680A1 (en) | 2014-01-03 |
WO2014003849A1 (en) | 2014-01-03 |
IL236184A0 (en) | 2015-01-29 |
MY172886A (en) | 2019-12-13 |
KR20150030673A (ko) | 2015-03-20 |
NZ703347A (en) | 2016-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO7240358A2 (es) | Uso de 2-metileno-19-nor-(20s)-1a, 25- dihidroxivitamina d3 para tratar el hiperparatiroidismo secundario | |
CO2019001193A2 (es) | Métodos y composiciones para el tratamiento de trastornos epilépticos | |
CL2018001845A1 (es) | Moduladores de la 5'-nucleotidasa, ecto y su uso | |
UY37036A (es) | Compuestos inhibidores de la quinasa de unión a tank | |
CL2017000554A1 (es) | Compuestos terapéuticamente activos y sus métodos de uso | |
UY36445A (es) | Compuestos moduladores de fxr (nr1h4 que contiene grupos hidroxi) | |
CR20150629A (es) | Compuestos químicos | |
CR20160272A (es) | REGULADORES DE Nrf2 | |
CL2014003572A1 (es) | Compuestos derivados de aril-sultamo o una sal del mismo, como moduladores de la funcion del receptor de orfano rorc; composicion que los contiene; y su uso para el tratamiento o la profilaxis de la artritis. | |
AR097481A1 (es) | Cocristales energéticos para el tratamiento de una formación subterránea | |
NI201400125A (es) | Antagonistas de st2l y métodos de uso | |
PE20170642A1 (es) | Cerradura electronica con nivelacion de uso y desgaste de una superficie tactil mediante un ingreso de codigo aleatorio | |
UY36224A (es) | Compuestos tricíclicos de imidazo-pirimidinona | |
GT201700023A (es) | Derivados de heterociclico opcionalmente condensados de piridimina útiles para el tratamiento de enfermedades inflamatorias, metabolicas, oncológicas y autoinmunitarias | |
CL2018002023A1 (es) | Uso de moduladores de receptores de gabaa para el tratamiento de picor. | |
CL2015000976A1 (es) | Compuestos de 2-fenil-5-heterociclil-tetrahidro-2h-piran-3-amina para uso en el tratamiento de diabetes y sus trastornos asociados. | |
CL2018002645A1 (es) | Sulfonamidas sustituidas para controlar plagas animales | |
UY37472A (es) | Sulfonilamidas sustituidas para combatir parásitos animales | |
CL2016001210A1 (es) | Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis. | |
SV2017005368A (es) | [1,2,4] triazolo [4,3-b] piridazinas para su uso en el tratamiento de enfermedades proliferativas | |
AR089320A1 (es) | Cepa de lactobacillus mucosae | |
UY34461A (es) | Compuestos de hidrocarburos aromáticos policíclic os que contienen un átomo de s o un grupo s(=o)2 en su estructura básica | |
BR112018067602A2 (pt) | ambrisentan para uso no tratamento de insuficiência renal aguda | |
CO2017003067A2 (es) | Compuestos de dipeptidil-cetoamida | |
CR20140051A (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida |